Po-Lin Lin
National Chiayi University(TW)Mackay Memorial Hospital(TW)Mackay Medical College(TW)State Council of the People's Republic of China(CN)Mackay Junior College of Medicine, Nursing and Management(TW)Community Health Center(US)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Glutathione Transferases and Polymorphisms, MicroRNA in disease regulation, Atrial Fibrillation Management and Outcomes
Most-Cited Works
- → Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2(2015)136 cited
- → IL-10 Promotes Tumor Aggressiveness via Upregulation of CIP2A Transcription in Lung Adenocarcinoma(2013)74 cited
- → MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc(2015)56 cited
- → MicroRNA-21 promotes tumour malignancy via increased nuclear translocation of β-catenin and predicts poor outcome in APC-mutated but not in APC-wild-type colorectal cancer(2014)54 cited
- → Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2(2016)53 cited
- → The YAP1/SIX2 axis is required for DDX3-mediated tumor aggressiveness and cetuximab resistance in KRAS-wild-type colorectal cancer(2017)